Therefore, we conducted a longitudinal study of colorectal cancer risk in which fasting serum insulin and glucose levels were measured at baseline and during follow-up in a subsample of participants in the Women's Health Initiative (WHI) clinical trials (CTs) and observational study (OS). The gene discussed is INS; the disease is colorectal cancer.